1-13 of 13
Hye Jin Kang, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Current Treatment Patterns and Outcomes in Patients with Peripheral T-Cell Lymphoma: Updated Results of the Nationwide, Multi-Center Prospective Registry Study (CISL 1404)

Hyungwoo Cho, MD, Dok Hyun Yoon, Dong-Yeop Shin, MD PhD, Sung-Soo Yoon, MD PhD, Seok Jin Kim, MD PhD, Young Rok Do, PhDMD, Gyeong-Won Lee, MD PhD, Kwak Jae-Yong, Yong Park, Min Kyoung Kim, MD PhD, Hye Jin Kang, MD PhD, Jun Ho Yi, MD PhD, Kwai Han Yoo, MD, Won Sik Lee, MD PhD, Park Byeong Bae, Jae-Cheol Jo, MD, Hyeon-Seok Eom, MD, Hyo Jung Kim, MD PhD, Jeong Seong Hyun, MD, Young-Woong Won, Byeong Seok Sohn, MD PhD, Jihyun Kwon, MD, Cheolwon Suh, Won Seog Kim, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2844.
https://doi.org/10.1182/blood-2019-129664
Published: 2019
Journal Articles

Open-Labeled, Multicenter Phase II Study of Bortezomib for Maintenance Therapy in Patients with High Risk Diffuse Large B Cell Lymphoma (DLBCL): Borma Trial from Consortium for Improving Survival of Lymphoma (CISL)

Jae-Cheol Jo, MD, Ho Sup Lee, MD, Cheolwon Suh, Hye Jin Kang, MD PhD, Won Seog Kim, MD PhD, HyeonSeok Eom, MD PhD, Inho Kim, MD PhD, Ho-Jin Shin, MD PhD, Yong Park, Won Sik Lee, MD PhD, Young Rok Do, PhDMD, Lee Gyeong-Won, Sung Yong Oh, Sung-Nam Lim, MD, Seong Yoon Lee, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2884.
https://doi.org/10.1182/blood-2019-132192
Published: 2019
Journal Articles

Results of Intercontinental Cooperative Non-Hodgkin T-Cell Lymphoma Prospective Registry Study

Sang Eun Yoon, Seok Jin Kim, MD PhD, Tsai-Yun Chen, MD, Yong Park, Li Mei Poon, MBBS, MRCP, FRCPath, Young Rok Do, PhDMD, Ho Sup Lee, MD PhD, Won Sik Lee, MD PhD, Hong-ghi Lee, MD PhD, Soon Thye Lim, MBBS, MRCP, Hye Jin Kang, MD PhD, Cosphiadi Irawan, Jae Joon Han, MD PhD, Hyo Jung Kim, MD PhD, Cheolwon Suh, Hwan Jung Yun, MD, Soo Chin Ng, FRCP, Jae-Cheol Jo, MD PhD, Byeong Seok Sohn, MD PhD, Sung Yong Oh, Yeung-Chul Mun, MD, Daryl Tan, MBBS, MRCP, Seong Kyu Park, MD, Jae-Yong Kwak, MD PhD, Ye Guo, MD PhD, Huilai Zhang, MD, Jun Zhu, MD PhD, Weili Zhao, MD PhD, Won Seog Kim, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4035.
https://doi.org/10.1182/blood-2019-126637
Published: 2019
Journal Articles

Pomalidomide, Cyclophosphamide, and Dexamethasone for Elderly, Transplant-Ineligible Patients with Relapsed and/or Refractory Multiple Myeloma Who Had Failed Treatment with Lenalidomide and Bortezomib: A Study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)

Ho Sup Lee, MD PhD, Chang-Ki Min, MD PhD, Kihyun Kim, MD, Seok Jin Kim, MD PhD, Je-Jung Lee, MD PhD, Inho Kim, MD PhD, Sung-Soo Yoon, MD PhD, Jin Seok Kim, MD PhD, Hyeon-Seok Eom, MD PhD, Dok Hyun Yoon, MD PhD, Cheolwon Suh, Ho-Jin Shin, MD PhD, Yeung-Chul Mun, MD, Min Kyoung Kim, MD PhD, Sung-Nam Lim, MD, Chul Won Choi, Hye Jin Kang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3114.
https://doi.org/10.1182/blood-2019-122404
Published: 2019
Journal Articles

Autologous EBV-Specific T Cells (CMD-003): Early Results from a Multicenter, Multinational Phase 2 Trial for Treatment of EBV-Associated NK/T-Cell Lymphoma

Won Seog Kim, MD, Ph. D., Kirit M. Ardeshna, MA MDFRCP FRCPath, Yi Lin, MD PhD, Yasuhiro Oki, MD, Jia Ruan, MD PhD, Eric D. Jacobsen, MD, Dok Hyun Yoon, MD PhD, Cheolwon Suh, MD PhD, Felipe Suarez, MD PhD, Pierluigi Porcu, MD, Jonathan E Brammer, MD, John Radford, MD, Lihua E. Budde, MD PhD, Jin Seok Kim, MD PhD, Gilles Salles, MD PhD, Catherine M. Bollard, MD FRACP, FRCPA, Arnaud Jaccard, Hye Jin Kang, MD PhD, Shannon Inman, Maryann Murray, BS, Kurt C. Gunter, MD, Daniel Y. Lee, MD PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MDDSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 4073.
https://doi.org/10.1182/blood.V130.Suppl_1.4073.4073
Published: 2017
Journal Articles

A Phase II Study of Brentuximab Vedotin for Relapsed or Refractory CD30-Positive Non-Hodgkin Lymphomas Other Than Anaplastic Large Cell Lymphoma

Silvia Park, Seok Jin Kim, MD PhD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Jin Seok Kim, MD PhD, Hye Jin Kang, MD PhD, Hyeon-Seok Eom, Mark Hong Lee, Cheolwon Suh, MD PhD, Won Seog Kim, MD, Ph. D.
Journal: Blood
Blood (2017) 130 (Supplement 1): 4077.
https://doi.org/10.1182/blood.V130.Suppl_1.4077.4077
Published: 2017
Journal Articles

A Prospective Registry Study of Peg-G-CSF Prophylaxis for Patients with Diffuse Large B-Cell Lymphoma (CISL 1403)

Jeong Seong Hyun, MD, Seok Jin Kim, MD PhD, Jung Yong Hong, Youngil Koh, MD, Hye Jin Kang, MD PhD, Yong Park, MD PhD, Gyeong-Won Lee, MD PhD, Won-Sik Lee, MD, Deok-Hwan Yang, MD PhD, Young Rok Do, MD PhD, Jae-Cheol Jo, MD PhD, HyeonSeok Eom, MD PhD, Kwai Han Yoo, Joon-ho Lee, Min Kyoung Kim, MD PhD, Park Byeong Bae, Jae-Yong Kwak, Seong Yoon Lee, MD, Ji-Hyun Kwon, MD, PhD, Jong-Ho Won, MD, Byeong Seok Sohn, PhD, Hyo Jung Kim, MD PhD, Hwan Jung Yun, MD, Dae-Sik Hong, MD PhD, Hojin Shin, Sung Yong Oh, Cheolwon Suh, MD PhD, Won Seog Kim, MD, Ph. D.
Journal: Blood
Blood (2017) 130 (Supplement 1): 2840.
https://doi.org/10.1182/blood.V130.Suppl_1.2840.2840
Published: 2017
Journal Articles

the Safety and Efficacy of Pomalidomide in Combination with Cyclophosphamide and Dexamethasone (PCD) in the Transplant-Ineligible Patients with Relapsed and/or Refractory Multiple Myeloma (MM) Who Had Lenalidomide Plus Dexamethasone (LD) Following Frontline Bortezomib Combined Chemotherapy, Open-Labeled, Multicenter Phase II Study

Ho Sup Lee, MD, Chang-Ki Min, MD PhD, Kihyun Kim, Seok Jin Kim, MD PhD, Je-Jung Lee, MD PhD, Inho Kim, MD PhD, Jin Seok Kim, MD PhD, Hyeon-Seok Eom, Dok Hyun Yoon, MD PhD, Cheolwon Suh, MD PhD, Ho-Jin Shin, MD, Yeung-Chul Mun, MD PhD, Min Kyoung Kim, MD PhD, Sung-Nam Lim, MD, Chul Won Choi, MD PhD, Hye Jin Kang, MD PhD, Sung-Soo Yoon, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1834.
https://doi.org/10.1182/blood.V130.Suppl_1.1834.1834
Published: 2017
Journal Articles

Unmet Needs for a Better Treatment in Patients with Peripheral T Cell Lymphoma: Data from a Nationwide, Multi-Center Prospective Registry Study (CISL 1404)

Dong-Yeop Shin, MDPhD, Jung Yong Hong, Koh Youngil, MD PhD, Seok Jin Kim, MD PhD, Lee Gyeong-Won, Kwak Jae-Yong, Young Rok Do, MD PhD, Yong Park, MD PhD, Joon-ho Lee, Hye Jin Kang, MD PhD, Won-Sik Lee, MD, Park Byeong Bae, Min Kyoung Kim, MD PhD, Jae-Cheol Jo, MD, Hyeon-Seok Eom, Jeong Seong Hyun, MD, Kwai Han Yoo, Kwon Ji-Hyun, Won Young-Woong, Byeong Seok Sohn, MDPhD, Kim Hyo Jung, Sung-Soo Yoon, MD PhD, Cheolwon Suh, MD PhD, Kim Won Seog
Journal: Blood
Blood (2017) 130 (Supplement 1): 4088.
https://doi.org/10.1182/blood.V130.Suppl_1.4088.4088
Published: 2017
Journal Articles

The Efficacy of JAK2 Inhibitor in Heavily Pretreated Classical Hodgkin Lymphoma: A Prospective Pilot Study of Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

Seok Jin Kim, MD PhD, Hye Jin Kang, MD PhD, Shin Dong-Yeop, MD PhD, Ho Sup Lee, Sung Yong Oh, MD, Ho-Jin Shin, MD PhD, Dok Hyun Yoon, Jung Yong Hong, MD, Jee Hyun Kong, Kana Sakamoto, Young Hyeh Ko, MD, Kengo Takeuchi, MD PhD, Cheolwon Suh, Won Seog Kim
Journal: Blood
Blood (2016) 128 (22): 1820.
https://doi.org/10.1182/blood.V128.22.1820.1820
Published: 2016
Journal Articles

Randomized Phase II Multi-Center Trial of Busulfan, Etoposide, and Cyclophosphamide Versus Busulfan, Etoposide, and Melphalan As Conditioning Therapy for Autologous Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from Consortium for Improving Survival of Lymphoma (CISL)

Kyoung Ha Kim, Lee Jae Hoon, Mark Lee, Kim Hoon-Gu, Young Rok Do, Yong Park, MD PhD, Sung Yong Oh, MD, Ho-Jin Shin, MD PhD, Won Seog Kim, Sung-Kyu Park, MD, Jong-Ho Won, Jee Hyun Kong, Moo-Rim Park, MD, Je-Jung Lee, Jae-Yong Kwak, Hye Jin Kang, MD PhD, Yeung-Chul Mun
Journal: Blood
Blood (2016) 128 (22): 3466.
https://doi.org/10.1182/blood.V128.22.3466.3466
Published: 2016
Journal Articles

Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

Seok Jin Kim, MD PhD, Hye Jin Kang, MD PhD, Dong-Yeop Shin, MD, Dok Hyun Yoon, Kana Sakamoto, MD, Jee Hyun Kong, MD, Young Hyeh Ko, MD PhD, Kengo Takeuchi, MD PhD, Cheolwon Suh, MD, PhD, Won Seog Kim, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4443.
https://doi.org/10.1182/blood.V124.21.4443.4443
Published: 2014
Journal Articles

Clinical Outcomes of R-CHOP Chemotherapy Alone Compared with R-CHOP Plus Radiotherapy in Patients with Localized, Non-Bulky Diffuse Large B-Cell Lymphoma

Ji Hyun Park, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Sang-wook Lee, Chan-Sik Park, MD, Jooryung Huh, Seok Jin Kim, MD PhD, Myung Hee Chang, MD, Hyeon Seok Eom, Yong Park, MD PhD, Jin Seok Kim, Soon Il Lee, Min Kyoung Kim, MD PhD, Young Rok Do, MD, Jong-Ho Won, Yeung-Chul Mun, Won Sik Lee, MD PhD, Hye Jin Kang, MD PhD, Hyo Jung Kim, MD PhD, Jung Hye Kwon, Jeong-A Kim, MD PhD, Jae-Yong Kwak, MDPhD, Jee Hyun Kong, MD, Sung Yong Oh, Sun Ah Lee, Jae Hoon Lee, Eun Kyung Park, Sung Hwa Bae, MD, Je-Jung Lee, Hyun Jung Jun, Yang Soo Kim, Hwan-Jung Yun, Won Seog Kim, Cheolwon Suh
Journal: Blood
Blood (2014) 124 (21): 4421.
https://doi.org/10.1182/blood.V124.21.4421.4421
Published: 2014